News

The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.

SynSmart and Amporin partner to advance small molecule therapies for degenerative diseases

Tuesday, April 21, 2026

SynSmart Rasayan Research Private Limited has entered into a collaboration with Amporin Pharmaceuticals AG to develop small molecule therapies aimed at treating severe degenerative diseases

PHARMAP 2026 Kicks Off Today in Amsterdam Uniting Pharma Leaders on Manufacturing and Packaging Innovations

Monday, April 20, 2026

The exclusive PHARMAP congress begins today in Amsterdam bringing together pharma executives for BB networking cuttingedge innovations and solutions in pharmaceutical manufacturing and packaging

Jeito Capital Closes Record $1.2 Billion Jeito II Fund for European Biopharma Investments

Friday, April 17, 2026

Parisbased Jeito Capital has closed billion for its second fund marking the largest raise by an independent European biopharmafocused venture capital fund

Aligos Therapeutics signs exclusive licensing deal with Amoytop for HBV treatment in Greater China

Friday, April 17, 2026

Aligos Therapeutics has entered into an exclusive licensing agreement with Xiamen Amoytop Biotech Co Ltd to develop and commercialise pevifoscorvir sodium for chronic hepatitis B virus HBV infection in Greater China including Mainland China Taiwan Ho...

Boehringer Ingelheim and Zai Lab Partner on DLL3-Targeting Combination Study in Lung and Neuroendocrine Cancers

Thursday, April 16, 2026

Boehringer Ingelheim and Zai Lab have announced a clinical collaboration to evaluate a dual DLLtargeting treatment approach The partnership will focus on a Phase IbII study assessing the safety tolerability

EU Records Significant Pharma Export Uptick in 2025 Amid Competitiveness Concerns

Wednesday, April 15, 2026

The European Union achieved a record trade surplus of bn in pharmaceuticals for driven by a yearonyear increase in export value though analysts warn of potential frontloading ahead of challenges

U.S. FDA Grants RMAT Designation to GS-100 for NGLY1 Deficiency

Wednesday, April 15, 2026

Grace Science LLC has received Regenerative Medicine Advanced Therapy RMAT designation from the US Food and Drug Administration FDA for GS an investigational gene therapy for the treatment of NGLY deficiency

Dyve Biosciences and Moffitt Cancer Center Report Promising Results for Novel Topical Therapy Targeting Tumour Acidity

Wednesday, April 15, 2026

Dyve Biosciences in collaboration with Moffitt Cancer Center has reported encouraging results for an investigational topical therapy designed to target tumour acidity across the body

Clinilabs Completes Routine FDA Inspection with No Observations

Wednesday, April 15, 2026

Clinilabs LLC a global fullservice contract research organisation CRO focused on the development of medicines and medical devices for the central nervous system has successfully completed a routine inspection by the US Food and Drug Administration FD...

Axplora Announces Expansion of R&D and Laboratory Hub at Farmabios Site in Italy

Tuesday, April 14, 2026

Axplora has announced plans to construct a new sqm RD and laboratory facility at its Farmabios site in Gropello Cairoli Italy to bolster manufacturing and innovation capabilities in the European pharma sector